Stock listing

F6T Stock Price, News, Filings & Events — Fate Therapeutics, Inc.

Selected listing: F6T · DUS · EUR · DE

F6T:DUS is the public listing for Fate Therapeutics, Inc., a biotechnology company dedicated to developing cellular immunotherapies for cancer and immune disorders. The company is actively engaged in research and development to advance its innovative therapies in regenerative medicine. With a market capitalization of approximately €280.9 million, Fate Therapeutics continues to make strides in the biotech sector, contributing to advancements in treatment options for patients. Recent news and filings may provide further insights into the company's progress and future initiatives.